Preliminary scientific studies show conolidine may possibly inhibit precise ion channels, minimizing neuronal excitability and limiting ache signals. This mechanism is particularly suitable in neuropathic ache, where by abnormal signaling causes persistent soreness. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathways